Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition.
about
Drug resistance in castration resistant prostate cancer: resistance mechanisms and emerging treatment strategiesEmerging data on androgen receptor splice variants in prostate cancerNiclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer.The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapiesAndrogen receptor splice variant 7 (AR-V7) and drug efficacy in castration-resistant prostate cancer: Biomarker for treatment selection exclusion or inclusion?Identification of Niclosamide as a Novel Anticancer Agent for Adrenocortical Carcinoma.Characterization of a novel p110β-specific inhibitor BL140 that overcomes MDV3100-resistance in castration-resistant prostate cancer cells.MicroRNA-181a promotes docetaxel resistance in prostate cancer cells.Inhibition of AKR1C3 Activation Overcomes Resistance to Abiraterone in Advanced Prostate Cancer.Progress in the mechanism and drug development of castration-resistant prostate cancer.Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting.Androgen receptor variation affects prostate cancer progression and drug resistance.Niclosamide: Beyond an antihelminthic drug.Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer.Clinical relevance of androgen receptor alterations in prostate cancer.Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer.Effect of mitochondrial uncouplers niclosamide ethanolamine (NEN) and oxyclozanide on hepatic metastasis of colon cancer.Adaptive pathways and emerging strategies overcoming treatment resistance in castration resistant prostate cancer.Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer.A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer.Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review).Th17 cell-derived IL-17A promoted tumor progression via STAT3/NF-κB/Notch1 signaling in non-small cell lung cancerInhibition of histamine receptor H3R suppresses prostate cancer growth, invasion and increases apoptosis via the AR pathway
P2860
Q26796704-023FE9F2-4D6E-4A5C-9AA5-D1FC89B432A5Q28077830-32C69BD3-EB68-400E-9AA6-BFA6F3F36B42Q30275354-CA746F49-E92A-4886-9AE1-DE1627D477B4Q36515479-574644B8-C9AF-4619-A439-86315C0F1204Q37013311-86B648D1-C9A2-4C31-932F-D7C307F9E93CQ37100097-22E5C7CE-B9F9-4E15-BB05-8D82FADFE192Q38699761-96172F5F-D5E7-40DF-A20F-C3CF442511CEQ38704252-9D343BFE-421E-4C51-954C-B58AA6B8124AQ38735379-4D75CE81-9DFD-49FD-8C4E-0945ECCF7F21Q38826609-696F1E8E-F4CC-42DF-8A3F-FB7FFE3E41B9Q38835693-ACA41AFF-B11E-44A2-83B4-3E3601D1EB04Q38977288-67E7735A-A756-461A-AAE1-F3DB4EB69FBEQ39227540-D3958A7C-D2A5-4FA2-922D-FB65F0A30832Q41561381-ED74ED35-8DD2-4C94-B393-30142B80FA10Q42377108-4A96BFB8-5B50-4355-95F6-7E862A7FD345Q46095028-B48AF7ED-8470-4779-8812-19862B519D88Q50025648-E3981FDB-1F3D-4621-BA9A-3E74EACCF793Q53735518-35D0D684-0649-4A08-80FB-82CE3EFEAD69Q55038918-06B22CE5-D1D7-4937-A581-EC1D76B391D3Q55208854-EE40C601-7765-4466-B2D1-6E10BDD49107Q55509415-E5BF494C-B0AD-43CE-BBD0-7CCA36B10903Q58129687-DA6DEC9F-5D4C-4DFA-B2EA-8AC099AC94AFQ58772565-660B0072-5E55-475D-8A05-18F9DCB5BE4B
P2860
Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Niclosamide suppresses cell mi ...... via Stat3-AR axis inhibition.
@en
type
label
Niclosamide suppresses cell mi ...... via Stat3-AR axis inhibition.
@en
prefLabel
Niclosamide suppresses cell mi ...... via Stat3-AR axis inhibition.
@en
P2093
P2860
P356
P1433
P1476
Niclosamide suppresses cell mi ...... via Stat3-AR axis inhibition.
@en
P2093
Allen C Gao
Cameron Armstrong
Chengfei Liu
Christopher P Evans
P2860
P304
P356
10.1002/PROS.23015
P577
2015-05-13T00:00:00Z